In this edition of our newsletter we focus on Pulmonology.
Please review some of the latest develpments and have a look at our selection of industry news.
- Respiratory Syncytial Virus (RSV) on target for drug development
- The impact of Duchenne Muscolar Dystrophy on pulmonary function
- Cystic Fibrosis treatment: the globalization of drug development and the role of the European Medicines Agency
For more information about our clinical development expertise and services, please get in touch with us.